Tools

LEADER 02493cam 2200445 i 4500

001 ocn842842137;

003 OCoLC;

005 20130806132344.0;

006 m o d f ;

007 cr |||||||||||;

008 130513s2013 dcua ob f000 0 eng c;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

050 14 a| KF27b| .W345 2012c;

074 a| 1028-C (online);

086 0 a| Y 4.W 36:112-OS 11;

088 a| Serial no. 112-OS11 (United States. Congress. House. Committee on Ways and Means);

245 10 a| Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medication :b| hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth Congress, second session, April 25, 2012.;

264 1 a| Washington :b| U.S. Government Printing Office,c| 2013.;

300 a| 1 online resource (iii, 82 pages) :b| illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Title from title screen (viewed May 13, 2013).;

500 a| Paper version available for sale by the Superintendent of Documents, United States Government Printing Office.;

504 a| Includes bibliographical references.;

500 a| "Serial no. 112-OS11.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

650 0 a| Drugs, Nonprescriptionx| Pricesz| United States.=| ^A387636;

650 0 a| Income tax deductions for medical expensesz| United States.=| ^A856538;

776 08 i| Print version:a| United States. Congress. House. Committee on Ways and Means. Subcommittee on Oversight.t| Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medicationw| (OCoLC)842841698;

776 08 i| Microfiche version:a| United States. Congress. House. Committee on Ways and Means. Subcommittee on Oversight.t| Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medicationw| (OCoLC)855115578;

856 40 u| https://purl.fdlp.gov/GPO/gpo36649;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 3322004;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 3322004-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 6/12/2013x| EDOCUMENTz| JERESOURCE;

Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medication : hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth Congress, second session, April 25, 2012.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Printing Office, 2013.
Description	1 online resource (iii, 82 pages) : illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo36649
Subjects	Drugs, Nonprescription--Prices. --United States. Income tax deductions for medical expenses--United States.

General note	Title from title screen (viewed May 13, 2013).
General note	Paper version available for sale by the Superintendent of Documents, United States Government Printing Office.
General note	"Serial no. 112-OS11."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Issued in other form	Print version: United States. Congress. House. Committee on Ways and Means. Subcommittee on Oversight. Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medication
Issued in other form	Microfiche version: United States. Congress. House. Committee on Ways and Means. Subcommittee on Oversight. Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medication
Technical rpt number	Serial no. 112-OS11 (United States. Congress. House. Committee on Ways and Means)
GPO item number	1028-C (online)
Govt. docs number	Y 4.W 36:112-OS 11

Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medication : hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth Congress, second session, April 25, 2012.

Click here for more information about this title